AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013
Jan 23, 2013
30583_dirs_2013-01-23_6c897024-e488-4527-9524-9d35545d6284.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-01-22
Reporting Person: BAFFI ROBERT (EVP, Technical Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-22 | Common Stock | M | 19575 | $17.54 | Acquired | 119988 | Direct |
| 2013-01-22 | Common Stock | S | 19575 | $55.00 | Disposed | 100413 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-22 | Stock Option (right to buy) Common Stock | $17.54 | M | 19575 | Disposed | 2016-11-19 | Common Stock (19575) | Direct |
Footnotes
F1: Transaction made pursuant to a Rule 10b5-1 plan executed on August 6, 2012.
F2: Options vest on May 20, 2007 and 1/48th on the 20th of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19